High‐frequency repetitive magnetic stimulation rescues ischemia‐injured neurons through modulation of glial‐derived neurotrophic factor present in the astrocyteʼs secretome
Open Access
- 19 December 2022
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 164 (6) , 813-828
Abstract
Due to its ability to improve the most frequent clinical sequelae left by ischemia, repetitive transcranial magnetic stimulation has been considered a promising therapeutic strategy for stroke. Those improvements are associated with changes in neurons and their synaptic liaisons. However, the hypothesis that this technique modulates astrocytes, potentiating their neuroprotective capabilities, was also raised. This study aims to identify the effects triggered by high‐frequency repetitive magnetic stimulation (HF‐rMS) on astrocytes that contribute to its neuroprotective effects. Neuron–glia and astrocyte cortical cultures subject to oxygen and glucose deprivation were used as an in vitro model of ischemia. Neuroprotection promoted by HF‐rMS was evaluated by analysis of markers of neuronal activity and morphometric analysis of neurons. Glial reactivity was determined by immunocytochemistry. The levels of growth factors in the astrocyte‐conditioned medium (CM) were assessed through a Growth Factor Array and glial‐derived neurotrophic factor (GDNF) expression was analyzed by RT‐PCR and Western blot. Our results show that neurons injured by ischemia can be rescued through the modulation of astrocytes by HF‐rMS. This modulation helps to maintain the number and length of neurites and increases the number of neurons expressing ERK1/2 and c‐Fos. Analysis of the astrocyte‐CM showed that HF‐rMS stimulated the release of several trophic factors by astrocytes. Moreover, GDNF was one of the released factors that contributed to the recovery mechanisms triggered by HF‐rMS. Our results show that modulation of astrocytes by HF‐rMS effectively rescues neurons injured by ischemia and suggest that by targeting astrocytes this approach can also be used to promote neuroprotection in other brain lesions. imageKeywords
Funding Information
- European Regional Development Fund (POCI‐01‐0145‐FEDER‐022122)
- Fundação para a Ciência e a Tecnologia (2021.07854.BD, UIDB/00709/2020, UIDB/Multi/00709/2019, UIDP/00709/2020, UIDP/Multi/00709/2019)
This publication has 49 references indexed in Scilit:
- Effects of Noninvasive Brain Stimulation on Language Networks and Recovery in Early Poststroke AphasiaStroke, 2013
- Degeneration of Axotomized Projection Neurons in the Rat dLGN: Temporal Progression of Events and Their Mitigation by a Single Administration of FGF2PLOS ONE, 2012
- Response of Hippocampal Neurons and Glial Cells to Alternating Magnetic Field in Gerbils Submitted to Global Cerebral IschemiaNeurotoxicity Research, 2012
- Mechanism of functional recovery after repetitive transcranial magnetic stimulation (rTMS) in the subacute cerebral ischemic rat model: neural plasticity or anti-apoptosis?Experimental Brain Research, 2011
- Repetitive Transcranial Magnetic Stimulation Enhances BDNF-TrkB Signaling in Both Brain and LymphocyteThe Journal of Neuroscience, 2011
- Long-term effects of rTMS on motor recovery in patients after subacute strokeJournal of Rehabilitation Medicine, 2010
- Protective effects of repetitive transcranial magnetic stimulation in a rat model of transient cerebral ischaemia: a microPET studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Acquisition of ischemic tolerance by repetitive transcranial magnetic stimulation in the rat hippocampusBrain Research, 2005
- Repetitive transcranial magnetic stimulation for protection against delayed neuronal death induced by transient ischemiaJournal of Neurosurgery, 2003
- Long-Term Repetitive Transcranial Magnetic Stimulation Increases the Expression of Brain-Derived Neurotrophic Factor and Cholecystokinin mRNA, but not Neuropeptide Tyrosine mRNA in Specific Areas of Rat BrainNeuropsychopharmacology, 2000